Organon to acquire Alydia Health after Merck spinoff

Merck announced that after its planned spinoff of Organon, Organon will acquire Alydia Health, a medical device company focused on postpartum hemorrhage. The transaction is expected to close after the spinoff. Financial terms were not disclosed.

“Merck and Alydia Health announced today that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health.”organon.com

• 1 source
• organon.comMerck Announces Acquisition of Alydia Health on behalf of its Planned Spinoff of Organon | OrganonMar 30, 2021

Summarized from public sources; check the original articles before acting on it.